Blue Trust Inc. decreased its position in Plexus Corp. (NASDAQ:PLXS – Free Report) by 75.5% during the 3rd quarter, according to its most recent filing with the SEC. The institutional investor owned 692 shares of the technology company’s stock after selling 2,136 shares during the period. Blue Trust Inc.’s holdings in Plexus were worth $95,000 as of its most recent filing with the SEC.
Several other institutional investors have also recently bought and sold shares of PLXS. American Century Companies Inc. lifted its stake in Plexus by 204.3% in the 2nd quarter. American Century Companies Inc. now owns 158,032 shares of the technology company’s stock valued at $16,306,000 after acquiring an additional 106,103 shares in the last quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. lifted its stake in Plexus by 8.8% in the 2nd quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. now owns 1,079,340 shares of the technology company’s stock valued at $111,366,000 after acquiring an additional 87,574 shares in the last quarter. Westfield Capital Management Co. LP lifted its stake in Plexus by 28.8% in the 1st quarter. Westfield Capital Management Co. LP now owns 384,248 shares of the technology company’s stock valued at $36,434,000 after acquiring an additional 85,986 shares in the last quarter. Vanguard Group Inc. lifted its stake in Plexus by 2.2% in the 1st quarter. Vanguard Group Inc. now owns 3,515,866 shares of the technology company’s stock valued at $333,374,000 after acquiring an additional 74,988 shares in the last quarter. Finally, Edgestream Partners L.P. bought a new stake in Plexus in the 1st quarter valued at approximately $3,934,000. Institutional investors own 94.45% of the company’s stock.
Plexus Trading Up 1.4 %
Shares of Plexus stock opened at $145.35 on Wednesday. Plexus Corp. has a 12-month low of $90.18 and a 12-month high of $153.60. The stock has a market cap of $3.96 billion, a P/E ratio of 36.25 and a beta of 0.89. The company has a quick ratio of 0.71, a current ratio of 1.51 and a debt-to-equity ratio of 0.07. The business’s 50 day moving average is $131.15 and its 200-day moving average is $116.73.
Insider Activity at Plexus
In related news, insider Victor (Pang Hau) Tan sold 1,000 shares of the stock in a transaction on Wednesday, August 28th. The stock was sold at an average price of $127.50, for a total value of $127,500.00. Following the sale, the insider now owns 8,605 shares in the company, valued at approximately $1,097,137.50. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other Plexus news, insider Steven J. Frisch sold 6,048 shares of the company’s stock in a transaction on Friday, August 16th. The stock was sold at an average price of $123.99, for a total value of $749,891.52. Following the transaction, the insider now directly owns 30,070 shares of the company’s stock, valued at $3,728,379.30. This represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, insider Victor (Pang Hau) Tan sold 1,000 shares of the company’s stock in a transaction on Wednesday, August 28th. The shares were sold at an average price of $127.50, for a total value of $127,500.00. Following the completion of the transaction, the insider now directly owns 8,605 shares in the company, valued at approximately $1,097,137.50. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders have sold 10,548 shares of company stock worth $1,315,152. Company insiders own 2.39% of the company’s stock.
Analyst Ratings Changes
Several research firms have commented on PLXS. Benchmark boosted their target price on Plexus from $150.00 to $165.00 and gave the company a “buy” rating in a research note on Monday. Needham & Company LLC upped their price objective on Plexus from $144.00 to $162.00 and gave the stock a “buy” rating in a research note on Friday, October 25th. KeyCorp assumed coverage on Plexus in a research note on Tuesday, October 22nd. They set a “sector weight” rating on the stock. Finally, StockNews.com upgraded Plexus from a “hold” rating to a “buy” rating in a research note on Tuesday. Three research analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $133.50.
View Our Latest Report on PLXS
Plexus Profile
Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.
Featured Articles
- Five stocks we like better than Plexus
- Insider Trading – What You Need to Know
- Is McDonald’s Stock a Smart Buy After Sell-Off and Earnings?
- What Are Dividend Challengers?
- QuantumScape: Solid State EV Batteries Nearing Commercialization
- What is the NASDAQ Stock Exchange?
- MicroStrategy: Is This Bitcoin-Powered Stock a Buy or a Gamble?
Want to see what other hedge funds are holding PLXS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Plexus Corp. (NASDAQ:PLXS – Free Report).
Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.